{
    "clinical_study": {
        "@rank": "101000", 
        "arm_group": [
            {
                "arm_group_label": "Platinum/fluoropyrimidine combination chemotherapy", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Fluoropyrimidine monochemotherapy", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators compare the overall survival between combination chemotherapy and\n      monochemotherapy as a first-line chemotherapy in elderly patients with metastatic or\n      recurrent gastric cancer. The investigators also compare the progression free survival,\n      response rate, safety, and, quality of life between two groups, and evaluate that the\n      comprehensive geriatric assessment tested at baseline can predict the toxicity and\n      compliance of treatment, survival of the patients."
        }, 
        "brief_title": "Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer", 
        "completion_date": {
            "#text": "February 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastric Cancer", 
        "condition_browse": {
            "mesh_term": "Stomach Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  .Metastatic or recurrent, histologically confirmed adenocarcinoma of stomach    -\n             Previously untreated patients, including patients with previous adjuvant\n             chemotherapy completed more than 6 months\n\n          -  70 yrs or older\n\n          -  Eastern Cooperative Oncology Group 0-2\n\n          -  Measurable or evaluable disease\n\n          -  Adequate major organ functions\n\n               -  Hb \u2265 9.0 g/dL\n\n               -  White blood cell count \u2265 3000/\u03bcL\n\n               -  Absolute Neutrophil Count (ANC) \u2265 1500/\u03bcL [*ANC  = neutrophil segs \uff0b neutrophil\n                  bands]\n\n               -  Platelet \u2265 100 \u00d7 103/ \u03bcL\n\n               -  Total bilirubin \u2264 1.5 \u00d7UNL, aspartate aminotransferase (AST)/alanine\n                  aminotransferase (ALT) \u2264 3.0x UNL(in case of liver metastasis,  AST/ALT  \u2264 5.0 x\n                  UNL)\n\n               -  Serum creatinine \u2264 1.5 \u00d7 UNL (in case of serum creatinine > 1.5 mg/dL , Ccr\n                  should be >= 50 mL/min, Ccr is calculated by Cockcroft-Gault or 24hr urine\n                  collection)\n\n          -  Life expectancy > 3month\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Metastatic or recurrent stomach cancer other than adenocarcinoma\n\n          -  HER-2 positive\n\n          -  Clinically significant, uncontrolled gastric outlet obstruction, bleeding, or\n             perforation\n\n          -  Radiation therapy within the previous 2wks\n\n          -  Major surgery or trauma within the previous 4wks\n\n          -  Other malignancies within the last 5 years (other than curatively treated basal cell\n             carcinoma of the skin and/or in situ carcinoma of the cervix)\n\n          -  Uncontrolled brain metastasis\n\n          -  Presence of other serious disease (cardiovascular, hepatic, infection etc.)\n\n          -  Patients who participated in other clinical trials within the previous 30days\n\n          -  Men of childbearing potential not willing to use effective means of contraception"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "332", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02114359", 
            "org_study_id": "20140113/16-2014-9/021"
        }, 
        "intervention": [
            {
                "arm_group_label": "Platinum/fluoropyrimidine combination chemotherapy", 
                "description": "Capecitabine/cisplatin (XP) : cisplatin 50mg/m2 (80% dose of 60mg/2m) iv over 15min D1, capecitabine 1000mg/m2 (80% dose of 1250mg/m2) po bid D1-14, q 3wks", 
                "intervention_name": "Capecitabine/cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Platinum/fluoropyrimidine combination chemotherapy", 
                "description": "S-1/cisplatin (SP) : cisplatin 50mg/m2 (80% dose of 60mg/2m) iv ov 15min D1, S-1 30mg/m2 (80% dose of 40mg/m2) po bid D1-14, q3wks", 
                "intervention_name": "S-1/cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Platinum/fluoropyrimidine combination chemotherapy", 
                "description": "Capecitabine+oxaliplatin (XELOX): oxaliplatin 100mg/m2 (80% dose of 130mg/m2)iv ov 120min D1, capecitabine 800mg/m2 (80% dose of 1000mg/m2) po bid D1-14, q3wks", 
                "intervention_name": "Capecitabine/oxaliplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Platinum/fluoropyrimidine combination chemotherapy", 
                "description": "5-fluorouracil/oxaliplatin (FOLFOX): oxaliplatin 80mg/m2 (80% dose of 100mg/m2) iv ov 120min, leucovorin 80mg/m2 (80% dose of 100mg/m2) iv ov 120min, 5-fluorouracil 1900mg/m2 (80% dose of 2400mg/m2) iv ov 46h D1, q 2wks", 
                "intervention_name": "5-fluorouracil/oxaliplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Fluoropyrimidine monochemotherapy", 
                "description": "Capecitabine : 1250mg/m2 po bid D1-14 q3wks (if Ccr <60ml/min, 1000mg/m2 po bid)", 
                "intervention_name": "Capecitabine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Fluoropyrimidine monochemotherapy", 
                "description": "S-1 : 40mg/m2 po bid D1-14 q3wks (if Ccr <60ml/min, 30mg/m2 po bid)", 
                "intervention_name": "S-1", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Fluoropyrimidine monochemotherapy", 
                "description": "5-fluorouracil (FL) : leucovorin 100mg/m2 iv ov 2h, 5-fluorouracil 2400mg/m2 iv ov 46h D1, q2wks", 
                "intervention_name": "5-fluorouracil", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxaliplatin", 
                "Capecitabine", 
                "Cisplatin", 
                "Fluorouracil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "gastric cancer, elderly, chemotherapy", 
        "lastchanged_date": "April 14, 2014", 
        "location": [
            {
                "contact": {
                    "email": "fhdzang@hallym.ac.kr", 
                    "last_name": "ZANG, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Anyang", 
                        "country": "Korea, Republic of", 
                        "zip": "431-796"
                    }, 
                    "name": "Hallym University Sacred Heart Hospital"
                }, 
                "investigator": {
                    "last_name": "ZANG, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "HAN, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Cheongju", 
                        "country": "Korea, Republic of", 
                        "zip": "361-711"
                    }, 
                    "name": "Chungbuk National University Hospital"
                }, 
                "investigator": {
                    "last_name": "HAN, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "SONG, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Chonju", 
                        "country": "Korea, Republic of", 
                        "zip": "561-712"
                    }, 
                    "name": "Chonbuk National University Hospital"
                }, 
                "investigator": {
                    "last_name": "SONG, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "KIM, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of", 
                        "zip": "702-210"
                    }, 
                    "name": "Kyungpook National University Medical Center"
                }, 
                "investigator": {
                    "last_name": "KIM, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "youngiee@dreamwiz.com", 
                    "last_name": "PARK, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Goyang", 
                        "country": "Korea, Republic of", 
                        "zip": "410-769"
                    }, 
                    "name": "National Cancer Center"
                }, 
                "investigator": {
                    "last_name": "PARK, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "SIM, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of", 
                        "zip": "400-713"
                    }, 
                    "name": "Gachon University Gil Medical Center"
                }, 
                "investigator": {
                    "last_name": "SIM, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "LIM, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of", 
                        "zip": "400-711"
                    }, 
                    "name": "Inha University Hospital"
                }, 
                "investigator": {
                    "last_name": "LIM, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "KIM, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Pusan", 
                        "country": "Korea, Republic of", 
                        "zip": "614-735"
                    }, 
                    "name": "Inje University Pusan Paik Hospital"
                }, 
                "investigator": {
                    "last_name": "KIM, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "SEOL, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Pusan", 
                        "country": "Korea, Republic of", 
                        "zip": "602-739"
                    }, 
                    "name": "Pusan National University Hospital"
                }, 
                "investigator": {
                    "last_name": "SEOL, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hmodoctor@hanmail.net", 
                    "last_name": "LEE, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seongnam", 
                        "country": "Korea, Republic of", 
                        "zip": "463-707"
                    }, 
                    "name": "Seoul National University Bundang Hospital"
                }, 
                "investigator": {
                    "last_name": "LEE, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "JUNG, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seongnam", 
                        "country": "Korea, Republic of", 
                        "zip": "463-712"
                    }, 
                    "name": "Bundang Cha Hospital"
                }, 
                "investigator": {
                    "last_name": "JUNG, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "OH, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "152-703"
                    }, 
                    "name": "Korea University Guro Hospital"
                }, 
                "investigator": {
                    "last_name": "OH, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "MAENG, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "130-872"
                    }, 
                    "name": "Kyung Hee University Hospital"
                }, 
                "investigator": {
                    "last_name": "MAENG, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "RYU, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "138-736"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "investigator": {
                    "last_name": "RYU, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "CHOI, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "156-707"
                    }, 
                    "name": "Seoul National University Boramae Hospital"
                }, 
                "investigator": {
                    "last_name": "CHOI, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "CHO, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-720"
                    }, 
                    "name": "Gangnam Severance Hospital"
                }, 
                "investigator": {
                    "last_name": "CHO, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "OH, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "investigator": {
                    "last_name": "OH, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study", 
        "other_outcome": {
            "description": "The investigaters are going to evaluate that comprehensive geriatric assessment  tested at baseline can predict the toxicity and compliance to treatment, survival of patients.\nComprehensive geriatric assessment will not necessarily be tested in all subjects, but instead, screening tool (KG-7 (Korean screening tool for the elderly)) will be tested in all subjects.", 
            "measure": "comprehensive geriatric assessment", 
            "safety_issue": "Yes", 
            "time_frame": "baseline"
        }, 
        "overall_contact": {
            "email": "hmoischoi@hanmail.net", 
            "last_name": "In Sil Choi, M.D., Ph.D.", 
            "phone": "82-10-9137-3883"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Boramae Hospital", 
            "last_name": "IN SIL CHOI, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "comparison of overall survival", 
            "safety_issue": "No", 
            "time_frame": "upto 3years"
        }, 
        "reference": [
            {
                "PMID": "8508349", 
                "citation": "Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin DB, Kim HT, Kim HJ, et al. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer. 1993 Jun 15;71(12):3813-8."
            }, 
            {
                "PMID": "12506170", 
                "citation": "Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S; Japan Clinical Oncology Group Study (JCOG9205). Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2003 Jan 1;21(1):54-9."
            }, 
            {
                "PMID": "10894863", 
                "citation": "Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol. 2000 Jul;18(14):2648-57."
            }, 
            {
                "PMID": "1801881", 
                "citation": "Lacave AJ, Bar\u00f3n FJ, Ant\u00f3n LM, Estrada E, De Sande LM, Palacio I, Esteban E, Gracia JM, Buesa JM, Fern\u00e1ndez OA, et al. Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial. Ann Oncol. 1991 Nov-Dec;2(10):751-4."
            }, 
            {
                "PMID": "19153121", 
                "citation": "Kang YK, Kang WK, Shin DB, Chen J, Xiong J, Wang J, Lichinitser M, Guan Z, Khasanov R, Zheng L, Philco-Salas M, Suarez T, Santamaria J, Forster G, McCloud PI. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009 Apr;20(4):666-73. Epub 2009 Jan 19."
            }, 
            {
                "PMID": "18282805", 
                "citation": "Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008 Mar;9(3):215-21. Epub 2008 Feb 20."
            }, 
            {
                "PMID": "18172173", 
                "citation": "Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008 Jan 3;358(1):36-46."
            }, 
            {
                "PMID": "18665164", 
                "citation": "Lee JL, Kang YK, Kang HJ, Lee KH, Zang DY, Ryoo BY, Kim JG, Park SR, Kang WK, Shin DB, Ryu MH, Chang HM, Kim TW, Baek JH, Min YJ. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer. 2008 Aug 19;99(4):584-90. Epub 2008 Jul 29."
            }, 
            {
                "PMID": "10765119", 
                "citation": "Koizumi W, Kurihara M, Nakano S, Hasegawa K. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology. 2000 Apr;58(3):191-7."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02114359"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Boramae Hospital", 
            "investigator_full_name": "In Sil Choi", 
            "investigator_title": "Clinical Associate Professor, Department of Internal Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "comparison of progression-free survival", 
                "safety_issue": "No", 
                "time_frame": "upto 2years"
            }, 
            {
                "measure": "comparison of response rate", 
                "safety_issue": "No", 
                "time_frame": "upto 2years"
            }, 
            {
                "measure": "comparison of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "upto 2yrs"
            }, 
            {
                "measure": "comparison of quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "upto 2years"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ministry of Health & Welfare, Korea", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Korean Cancer Study Group", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}